Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Shanghai Junshi Bioscience Co., Ltd.
Eli Lilly and Company
National Cancer Institute (NCI)
Western Regional Medical Center
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
University of Chicago
SWOG Cancer Research Network
Central European Cooperative Oncology Group
Kidney Cancer Research Bureau
Kidney Cancer Research Bureau
Spanish Oncology Genito-Urinary Group